Dr Al-Jehani is a Consultant Haematologist with over 16 years of haemato-oncology experience. He is the clinical lead of the haematology department at Croydon University Hospital, London and also undertakes private work with the Shirley Oaks hospital in London and GenesisCare Maidstone in Kent. He has a specialist interest in haemato-oncology including myeloma; lymphomas and leukaemias. Alongside his clinical work he has also had an active role in teaching doctors in training, held the role of the appraiser and principal investigator of AML19, PETRea, MCL bank and Myeloma FiTness clinical trials at Croydon University Hospital. Dr Al-Jehani's broad training background and current specialised role mean that he can provide the perfect combination of high-level diagnostics and individualised cutting-edge care.

Dr Al-Jehani's main interests are in the diagnosis and treatment of patients with haematological disorders including leukaemia, lymphoma, myeloma, myelodysplasia and myeloproliferative disorders. Also, treats patients with anaemias, polycythaemia, low/high white cell and/or platelet counts, high ferritin and lymph gland swelling. He can treat patients with chemotherapy and biological targeted therapies such as antibodies, small molecules (often tablets).

Dr Al-Jehani is happy to provide second opinions if requested. He works with a talented team of clinicians, pathologists and radiologists to provide the very best advice in terms of diagnosis and treatment.

Broad training background:

Dr Al-Jehani qualified as a medical doctor in 1989 and completed his internship before joining the general medical rotation at the main teaching hospital in Benghazi, Libya. During this period he gained experience in the care of acutely ill patients and performed day-to-day ward and outpatient clinic work. Dr Al-Jehani also had his first experience in haematology as an SHO, participating in ward rounds and 1-in-4 on-call rotas. He was responsible for administering chemotherapy to patients with haematological malignancies and performing bedside procedures such as bone marrow aspirations and lumbar punctures.

After earning an internal medicine diploma from London University, Dr Al-Jehani passed the MRCP(UK) on his first attempt. He subsequently completed an MSc in Haematology at Hammersmith Hospital, where he gained expertise in diagnostic techniques and haematology research, culminating in two original publications. As an Honorary Registrar under Professor J. Goldman, Dr. Al-Jehani conducted outpatient clinics, participated in ward rounds, and completed a research project in the Leukaemia Research Laboratory.

In 2002, Dr Al-Jehani joined the Southwest London Specialist Registrar rotation in haematology, training at institutions such as The Royal Marsden Hospital, St. George’s Hospital, and Frimley and Guildford hospitals. Under the mentorship of eminent haematology experts, he developed expertise in clinical and laboratory haematology, alongside managerial and leadership skills.

His experience in the UK introduced him to multidisciplinary approaches, evidence-based medicine, and team-based care, which further enhanced his leadership abilities. He has held executive and leadership roles in one of Libya’s largest medical centres, where he demonstrated proficiency in decision-making, team formation, and strategic planning.

By working in high executive and leadership posts in one of the biggest and most important healthcare medical centres in Libya, he acquired a high level of skill in making sound and quick decisions, forming and leading teams, and strategic planning.

He also initiated several initiatives to improve healthcare services and to enhance patient-centred care policies. One successful initiative was the Benghazi Hospitals Group. The aim of this was to have all higher executive leaders from the seven hospitals in Benghazi meet regularly to plan services, arrange patient transfers, discuss needs and budgets, and communicate directly with the local city council and the Ministry of Health.

Furthermore, Dr Al- Jehani successfully started international projects with elite healthcare institutes, including working with Massachusetts General Hospital in Boston, USA, to improve emergency care over the course of three years. After signing an agreement with the International Foundation of Children with Heart Diseases (IFCH) based in Memphis, Tennessee, USA, he initiated a successful paediatrics open-heart surgery program. As well as this he signed a partnership agreement with the King Hussain Cancer Centre in Amman, Jordan, to further develop cancer services at the Benghazi Medical Centre. This involved training laboratory staff, oncology nurses, radiotherapy and nuclear medicine technicians as well as doctors. Finally he transferred laboratory samples, including histopathology reviews, and referred patients for stem cell autografts.

• General haematology

Specialties: Haemato-onclogy including:

• Myeloma
• Lymphomas
• Leukaemias

• General Medical Council
• Royal College of Physicians
• Royal College of Pathologists